Back to search
Acute Myelogenous Leukemia (AML) Due to Therapy
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Acute Myelogenous Leukemia (AML) Due to Therapy trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Acute Myelogenous Leukemia (AML) Due to Therapy trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This is a phase 2 single-arm, open-label clinical trial determining efficacy of CPX-351 in combination with Glasdegib in subjects with Acute Myelogenous Leukemi…
RATIONALE: Antiemetic drugs, such as ondansetron, may help to reduce or prevent nausea and vomiting in patients with advanced cancer. PURPOSE: This randomized…